Aravive, Inc. Common Stock
ARAV
ARAV was delisted on the 26th of January, 2024.
65 hedge funds and large institutions have $394M invested in Aravive, Inc. Common Stock in 2015 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 39 increasing their positions, 9 reducing their positions, and 3 closing their positions.
333% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 9
300% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 3
16% more funds holding
Funds holding: 56 → 65 (+9)
2% more capital invested
Capital invested by funds: $386M → $394M (+$8.43M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$16M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
+$13.6M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$12.6M |
| 4 |
PA
Perceptive Advisors
New York
|
+$12M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$8.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$7.67M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$5.28M |
| 3 |
NLVP
New Leaf Venture Partners
New York
|
-$5.03M |
| 4 |
Goldman Sachs
New York
|
-$3.62M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$587K |
ARAV Hedge Fund Activity: Q1 2015 in Review
65 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Aravive, Inc. Common Stock (ARAV) for Q1 2015, worth a combined $394M — up 2.2% from $386M a quarter earlier.
Buyers outnumbered sellers: 12 funds opened new ARAV positions and 3 closed out — a net gain of 9 holders — while 39 added to existing stakes and 9 trimmed.
The largest buyer was Federated Hermes, adding an estimated $16M. The largest seller was PFM Health Sciences, cutting an estimated $7.67M.
- 65 institutional investors held Aravive, Inc. Common Stock (ARAV) as of Q1 2015, up from 56 in Q4 2014.
- Funds reported $394M of Aravive, Inc. Common Stock stock for Q1 2015, up 2.2% quarter-over-quarter.
- 12 funds opened new Aravive, Inc. Common Stock positions in Q1 2015 and 3 closed out, a net change of +9 holders.
- The largest Aravive, Inc. Common Stock buyer in Q1 2015 was Federated Hermes, an estimated $16M added.
- The largest Aravive, Inc. Common Stock seller in Q1 2015 was PFM Health Sciences, an estimated $7.67M sold.
Based on aggregated 13F filings for Q1 2015.